Traduction de «Thérapie de soutien par l'expression » (Français → Anglais) :

Research will focus on: developing promising candidate interventions (vaccines, therapies and HIV microbicides) against the target diseases by sponsoring research over the full spectrum from basic molecular research, taking advantage of microbial genomics, through to pre-clinical testing and proof-of-principle; establishing a clinical trials programme to unite and support Europe's clinical trial activities specifically targeted at interventions for use in developing countries; establishing an AIDS Therapy Trials Network in Europe to ...[+++] improve the coherence and complementarity of clinical trials of AIDS therapies for European use.

Support in this area will be granted for, among other activities: pharmacogenomic approaches; cell therapy, including therapy using adult stem cells and adult "reprogrammed" somatic cells; research into ethically acceptable alternatives to technologies which are controversial within the Community and Member States, e.g. alternatives to experiments on animals and to embryonal stem cell research and artificial insemination methods that could prevent the production of supernumerary embryos; support for innovative research on transgenic plants for the production of drugs, hormones and proteins for therapeutic purposes; innovative researc ...[+++]h in post-genomics and related molecular mechanisms, which has a high potential for application, including stem-cell therapies in neurological and neuromuscular disorders.

Research will focus on: developing promising candidate interventions (vaccines, therapies and HIV microbicides) against the target diseases by sponsoring research over the full spectrum from basic molecular research, taking advantage of microbial genomics, through to pre-clinical testing and proof-of-principle; establishing a clinical trials programme to unite and support Europe"s clinical trial activities specifically targeted at interventions for use in developing countries; establishing an AIDS Therapy Trials Network in Europe to ...[+++] improve the coherence and complementarity of clinical trials of AIDS therapies for European use.

Although a scientific base of a given size tends at least to some extent to imply that specific measures are being taken to promote gene therapy, it is difficult to draw conclusive inferences as to the reasons. Many of the larger countries are strong in biotechnological research in general and can therefore be presumed to be equally strong in gene therapy, whether or not they provide specific funding.

R. whereas the European Union has a duty to encourage research in biotechnologies and human genetics; whereas fundamental research must not be left solely to the commercial sector, and whereas the public interest requires strong support for all forms of research likely to increase knowledge of the human being and, in time, to help to devise new therapies; whereas national prohibitions relating to certain types of research must not prevent the European Union as a whole from supporting such research in those countries in which it is lawf ...[+++]ul ; whereas only research leading to the cloning of human beings and changes to the germ line should be prohibited, and whereas therapies should be developed only with a view to treating serious diseases and not to improving new human characteristics,

Scientific support is foreseen to enhance surveillance capacity, models and systems, to improve detection methods and disease and risk assessment models, to strengthen networking activities for new vaccines and therapeutics, and to assess vulnerabilities of modern societies.